Infectious Disease Diagnostics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

The Infectious Disease Diagnostics Market is segmented by Application (Bacterial Infection, Cardiovascular infection, CNS Infections, Fungal infection, Gastro-Intestinal Infection, Sexually Transmitted Disease, Viral Infection, Other Applications), By Product, by Technology, and Geography.

Infectious Disease Diagnostics Market Snapshot

Infectious Disease Diagnostics Market
Study Period: 2018 - 2026
Base Year: 2020
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 5.47 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

Infectious diseases are one of the leading causes of morbidity and mortality across the globe. Diagnostics is the primary step for the disease discovery and treatment leading to eradication of infectious diseases. Owing to ever-evolving pathogens and emerging new diseases, there is dire need to identify suitable diagnostics technique that can help physicians to decide appropriate treatment. This can also help to control the outbreak of the disease in the population. Technological advancement has rapidly changed the landscape of infectious disease diagnostics. Scientific research and development activities in novel technologies and technique  such  as mass  spectrometry  and  next-generation sequencing (NGS)  are changing  the way  how rapid diagnostics are being performed to detect diseases. In addition, growing inclination of  end-user towards point-of-care  testing  is  also anticipated  to  drive  the  industry growth. The point-of-care diagnostics provide rapid actionable information for patients care at the  real-time and site of  an encounter with the  healthcare system. Additionally, various major players are focused on research and development activities to develop point-of-care diagnostics solution for developing countries.

Scope of the Report

As per the scope of the report infectious disease diagnostics involves identifying the presence of foreign antigen/organism using diagnostic tools such as kits and/or device. In the report, a detailed analysis of the Infectious disease diagnostics market is provided. The market is evaluated by collating revenues generated across segments, categorized by product, technology, application and geography.

By Application
Hepatitis
Human Immunodeficiency Virus (HIV)
Chlamydia Trachomatis Genital Infection and Gonorrhea (CT/NG)
Hospital-Acquired Infections
Human Papillomavirus (HPV)
Tuberculosis (TB)
Influenza
Other Infectious Diseases
By Product
Assays, Kits, & Reagents
Instruments
Services & Software
By Technology
Polymerase Chain Reaction (PCR)
Isothermal Nucleic Acid Amplification Technology (INAAT)
Immunodiagnostics
DNA Microarray
Clinical Microbiology
DNA Sequencing & Next-Generation Sequencing (NGS)
Others
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Viral Infection diagnostics are expected to cover a large share of the market

A viral infection is one of the major public health concerns around the world. As per a report by Meryem Jefferies et al. published in the World Journal of Clinical Cases 2018, every year 1.4 million people die from viral hepatitis-related cirrhosis and liver cancer. Furthermore, according to the World Health Organization, 37.9 million people were living with HIV/AIDS worldwide in 2018. Moreover, an estimated 32 million people have died of HIV.

Thus, owing to the high prevalence of these dreadful illnesses, the demand for early diagnostic tests is expected to increase as early diagnosis may reduce the spread of the disease. Hence, this market is expected to increase in the future.

Infectious Disease Diagnostics Market

North America is expected to Hold Largest Market Share

According to Charbel el Bcheraoui et al. published in the Journal of the American Medical Association 2018, between 1980 and 2014, there were more than 4 million deaths due to infectious diseases recorded in the United States. In 2014, a total of more than 110,000 deaths (a rate of 34.10 deaths per 100 000 persons) were due to infectious diseases in the United States.

As United States is developed economy, it has a well-structured healthcare system. This has helped the country with better access to the diagnostic tests that are available in the market. Diagnostic tests help early diagnostic of disease which can help the spread of these infectious diseases. As a result, this can noticed in the decreasing rate of infectious diseases over the years. However, the rate still remains high, which is expected to help the growth of this market

Infectious Disease Diagnostics Market

Competitive Landscape

Majority of the Infectious disease diagnostics are being manufactured by the global key players. Market leaders with more funds for research and better distribution system have established their position in the market. Moreover, Asia-pacific is witnessing an emergence of some small players due to the rise of awareness. This has also helped the market growth.

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Prevalence of Infectious Diseases

      2. 4.2.2 Shift in Focus From Centralized Laboratories to Decentralized Point-Of-Care Testing

      3. 4.2.3 Research on Infectious Disease Diagnostics

    3. 4.3 Market Restraints

      1. 4.3.1 Inadequate Reimbursements

      2. 4.3.2 Rising Healthcare Costs Limiting the Use of Novel Diagnostic Techniques

    4. 4.4 Porter’s Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Application

      1. 5.1.1 Hepatitis

      2. 5.1.2 Human Immunodeficiency Virus (HIV)

      3. 5.1.3 Chlamydia Trachomatis Genital Infection and Gonorrhea (CT/NG)

      4. 5.1.4 Hospital-Acquired Infections

      5. 5.1.5 Human Papillomavirus (HPV)

      6. 5.1.6 Tuberculosis (TB)

      7. 5.1.7 Influenza

      8. 5.1.8 Other Infectious Diseases

    2. 5.2 By Product

      1. 5.2.1 Assays, Kits, & Reagents

      2. 5.2.2 Instruments

      3. 5.2.3 Services & Software

    3. 5.3 By Technology

      1. 5.3.1 Polymerase Chain Reaction (PCR)

      2. 5.3.2 Isothermal Nucleic Acid Amplification Technology (INAAT)

      3. 5.3.3 Immunodiagnostics

      4. 5.3.4 DNA Microarray

      5. 5.3.5 Clinical Microbiology

      6. 5.3.6 DNA Sequencing & Next-Generation Sequencing (NGS)

      7. 5.3.7 Others

    4. 5.4 Geography

      1. 5.4.1 North America

        1. 5.4.1.1 United States

        2. 5.4.1.2 Canada

        3. 5.4.1.3 Mexico

      2. 5.4.2 Europe

        1. 5.4.2.1 Germany

        2. 5.4.2.2 United Kingdom

        3. 5.4.2.3 France

        4. 5.4.2.4 Italy

        5. 5.4.2.5 Spain

        6. 5.4.2.6 Rest of Europe

      3. 5.4.3 Asia-Pacific

        1. 5.4.3.1 China

        2. 5.4.3.2 Japan

        3. 5.4.3.3 India

        4. 5.4.3.4 Australia

        5. 5.4.3.5 South Korea

        6. 5.4.3.6 Rest of Asia-Pacific

      4. 5.4.4 Middle-East and Africa

        1. 5.4.4.1 GCC

        2. 5.4.4.2 South Africa

        3. 5.4.4.3 Rest of Middle-East and Africa

      5. 5.4.5 South America

        1. 5.4.5.1 Brazil

        2. 5.4.5.2 Argentina

        3. 5.4.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Biomérieux SA

      2. 6.1.2 Abbott Laboratories

      3. 6.1.3 Becton, Dickinson and Company

      4. 6.1.4 Bio-Rad Laboratories

      5. 6.1.5 Danaher Corporation

      6. 6.1.6 F. Hoffmann-La Roche AG

      7. 6.1.7 Siemens Healthineers

      8. 6.1.8 Thermo Fisher Scientific

      9. 6.1.9 Quidel Corporation

      10. 6.1.10 Luminex

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Infectious Disease Diagnostics Market market is studied from 2018 - 2026.

The Infectious Disease Diagnostics Market is growing at a CAGR of 5.47% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2020.

BioMérieux SA, F. Hoffmann-La Roche Ltd, Luminex, Becton, Dickinson and Company., Abbott Laboratories are the major companies operating in Infectious Disease Diagnostics Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!